From 2008 to 2022, the incidence of cervical precancers fell by 80% among screened women aged 20 to 24 years, supporting recommendations for HPV vaccination at ages 11 to 12 years, researchers wrote in Morbidity and Mortality Weekly Report.

Despite a proven survival benefit, the addition of pembrolizumab (Keytruda) to chemoradiotherapy for newly diagnosed locally advanced cervical cancer was not cost-effective in an economic evaluation study.

Bandi and her team found that past-year cervical cancer screenings in 2023 remained at 14%, which is below pre-pandemic levels. “We want to detect cancers early when they’re more treatable,” Bandi said.

After a long decline, cervical cancer rates are rising in rural counties, increasing a gap with urban counties, a new study finds.

Discover the vital warning signs of cervical cancer that doctors say Black women need to watch for, and learn why early detection can make all the difference.

Cervical cancer incidence is rising, with rural and minoritized populations experiencing worse outcomes due to suboptimal care and screening disparities. Data from 2001-2019 reveal a widening gap in cervical cancer rates between rural and urban women,

Many Americans remain unaware of the cancer risk for both men and women posed by human papillomavirus, a new Ohio State University poll has found.

Most of the women under 30 with cervical cancer in the Netherlands have not been vaccinated against HPV. A study conducted by gynecologists from Amsterdam UMC in collaboration with the Comprehensive Cancer Centre of the Netherlands (IKNL) found that only 15 percent of young women with cervical cancer had been vaccinated against the virus that most commonly causes this cancer,